According to U.S. Physical Therapy's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 49.886. At the end of 2022 the company had a P/E ratio of 36.0.
Year | P/E ratio | Change |
---|---|---|
2022 | 36.0 | -8.79% |
2021 | 39.5 | -18.57% |
2020 | 48.5 | 3.89% |
2019 | 46.7 | -40.26% |
2018 | 78.1 | 89.37% |
2017 | 41.3 | -0.09% |
2016 | 41.3 | 36.16% |
2015 | 30.3 | 18.54% |
2014 | 25.6 | -23.08% |
2013 | 33.3 | 83.59% |
2012 | 18.1 | 64.8% |
2011 | 11.0 | -26.22% |
2010 | 14.9 | -11.1% |
2009 | 16.8 | 5.63% |
2008 | 15.9 | -17.18% |
2007 | 19.2 | -15.54% |
2006 | 22.7 | -9.11% |
2005 | 25.0 | -7.74% |
2004 | 27.1 | 11.79% |
2003 | 24.2 | 67.12% |
2002 | 14.5 | -36.98% |
2001 | 23.0 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
DaVita DVA | 27.4 | -45.13% | ๐บ๐ธ USA |
Acadia Healthcare
ACHC | 22.0 | -55.89% | ๐บ๐ธ USA |
Select Medical Holdings SEM | 21.4 | -57.13% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.